WallStreetZenWallStreetZen

NASDAQ: TVTX
Travere Therapeutics Inc Stock Ownership - Who owns Travere Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Travere Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Christopher R. ClineCHIEF FINANCIAL OFFICER2026-02-04110$32.90
$3.62kSell
Jula InrigCHIEF MEDICAL OFFICER2026-02-041,547$32.11
$49.67kSell
Jula InrigCHIEF MEDICAL OFFICER2026-02-04232$32.85
$7.62kSell
Christopher R. ClineCHIEF FINANCIAL OFFICER2026-02-041,635$32.14
$52.55kSell
Elizabeth E. ReedChief Legal Officer and GC2026-02-04509$32.74
$16.66kSell
Elizabeth E. ReedChief Legal Officer and GC2026-02-042,485$32.07
$79.69kSell
Eric M. DubeCHIEF EXECUTIVE OFFICER2026-02-0366,452$32.06
$2.13MSell
Eric M. DubeCHIEF EXECUTIVE OFFICER2026-02-0333,635$32.70
$1.10MSell
Elizabeth E. ReedChief Legal Officer and GC2026-02-037,175$32.12
$230.46kSell
Sandra CalvinSVP CHIEF ACCOUNTING OFFICER2026-02-034,333$32.12
$139.18kSell

1 of 8

TVTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TVTX insiders and whales buy or sell their stock.

TVTX Shareholders

What type of owners hold Travere Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ruth Shepley54.77%49,000,000$1.46BInsider
Janus Henderson Group PLC11.85%10,599,660$314.92MInstitution
Blackrock Inc9.05%8,100,461$240.66MInstitution
Armistice Capital LLC7.52%6,724,000$199.77MInstitution
Vanguard Group Inc7.39%6,613,368$196.48MInstitution
Macquarie Group Ltd5.57%4,984,333$148.08MInstitution
Perceptive Advisors LLC4.24%3,794,615$112.74MInstitution
Adage Capital Partners GP LLC3.97%3,552,000$105.53MInstitution
State Street Corp3.60%3,217,839$95.60MInstitution
Fmr LLC3.23%2,894,148$85.99MInstitution

1 of 3

TVTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TVTX63.45%36.55%Net SellingNet Selling
BEAM86.38%13.62%Net SellingNet Selling
SYRE71.36%28.64%Net SellingNet Selling
ALMS74.42%25.58%Net BuyingNet Buying
TARS73.40%26.60%Net SellingNet Selling
View Top Biotech Stocks

Travere Therapeutics Stock Ownership FAQ

Who owns Travere Therapeutics?

Travere Therapeutics (NASDAQ: TVTX) is owned by 112.58% institutional shareholders, 64.85% Travere Therapeutics insiders, and 0.00% retail investors. Ruth Shepley is the largest individual Travere Therapeutics shareholder, owning 49.00M shares representing 54.77% of the company. Ruth Shepley's Travere Therapeutics shares are currently valued at $1.46B.

If you're new to stock investing, here's how to buy Travere Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.